Stay updated on ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's revision number.
    Difference
    0.1%
    Check dated 2026-08-09T08:53:42.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.4, indicating a minor update to the ClinicalTrials.gov record. No study data or criteria appear to be altered.
    Difference
    0.1%
    Check dated 2026-07-25T18:15:34.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The study's recruitment status was updated to 'Active, not recruiting' with a note that no participants are being sought, indicating enrollment has closed. Several investigator and contact details were removed, reducing publicly listed study contacts.
    Difference
    4%
    Check dated 2026-07-11T14:29:21.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.2 to v3.6.3, indicating a new version of the page or its underlying system. This update does not alter the study details or other content presented.
    Difference
    0.0%
    Check dated 2026-07-04T08:21:06.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    A new page revision tag v3.6.2 was added and the previous v3.6.0 tag removed, indicating a minor update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-27T05:59:28.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    New navigation/help items were added, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment heading was standardized (Intervention / Treatment vs Intervention/Treatment). The page revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T04:45:01.000Z thumbnail image

Stay in the know with updates to ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial page.